Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
T-complex protein 11 homolog (TCP11) is a testis-specific protein crucial for male fertility, particularly for the processes of spermatogenesis, sperm maturation, and motility[1][2][3]. It functions as the putative receptor for fertilization-promoting peptide (FPP)[1][3]. In both mouse and human, TCP11 is highly expressed in the testis—with variant expression in tissues such as brain and epididymis in humans—and localizes to structures such as the acrosomal vesicle and sperm flagellum[1][2][3]. TCP11 is required for sperm tail structural integrity and motility, and its deficiency is associated with morphological abnormalities and impaired sperm function, leading to male infertility[1][2][3]. TCP11 appears to regulate sperm capacitation, potentially via the cAMP/PKA signal transduction pathway[2][3]. Recent evidence suggests TCP11 may also play a role in cancers such as cervical cancer, where altered expression affects cellular proliferation and apoptosis[1]. However, its major characterized function is in germ cell development and male fertility. TCP11 is not established as a therapeutic target, biomarker, or druggable protein in current clinical use[1][2][3].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on T-complex protein 11 homolog (TCP11).